Samantha Huang

Samantha Huang

Auto-generated profile, based on publicly available information

Samantha Huang

From the Division of Plastic, Reconstructive, Hand and Burn Surgery, Department of Surgery, University of New Mexico, Albuquerque, New Mexico

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Burns
Verified
Journal Article
Closed access
SHSamantha Huang
Samantha Huang
JDJustin Dang
Justin Dang
CSClifford C. Sheckter
Clifford C. Sheckter
HYHaig A. Yenikomshian
Haig A. Yenikomshian
JGJustin Gillenwater
Justin Gillenwater

7 April 2022 in Journal of Surgical Oncology
Verified
Journal Article
Open access
SHSamantha Huang
Samantha Huang
VPVishwas Parekh
Vishwas Parekh
JWJames Waisman
James Waisman
VJVeronica Jones
Veronica Jones
YYYuan Yuan
Yuan Yuan
WLWai‐Yee Li
Wai‐Yee Li
Cutaneous metastases (CM) are neoplastic lesions involving the dermis or subcutaneous tissues, originating from another primary tumor. Breast cancer is commonest primary solid tumor, representing 24%–50% of CM patients. There is no “standard of care” on management. In particular, the role of surgery in the treatment of cutaneous metastases from breast carcinoma (CMBC) remains controversial. This systematic review evaluates the role of cutaneous metastasectomy in breast cancer and provides an overview of existing treatment types.

4 September 2021 in Journal of Community Health
Verified
Journal Article
Closed access
PDF file
SHSamantha Huang
Samantha Huang
GBGabriella Blissett
Gabriella Blissett
BPBing April Pei
Bing April Pei
NBNina Balac
Nina Balac
JBJessica Bogner
Jessica Bogner
JRJo Marie Reilly
Jo Marie Reilly

15 July 2025 in ASAIO Journal
Verified
Journal Article
Closed access
SHSamantha Huang
Samantha Huang
DBDominick Byrd
Dominick Byrd
ALAvra Laarakker
Avra Laarakker
SSShawhin Shahriari
Shawhin Shahriari
GBGregory Borah
Gregory Borah
Digital ischemia following extracorporeal membrane oxygenation (ECMO) therapy is a known complication with potential devastating long-term sequela. Onabotulinum toxin type A (BTX-A) has been demonstrated to be effective for digital ischemia in adults with Raynaud’s phenomenon. The objective of this study is to describe the use of BTX-A in pediatric and neonatal patients with digital ischemia following ECMO therapy. Three consecutive patients with digital ischemia after ECMO therapy were included. Patient ages ranged from 3 days to 13 months. Twenty-five to 50 units of BTX-A were injected to each affected extremity targeting the areas around the known arterial anatomy of the hands and feet. On post-injection day one, all patients demonstrated improvement in ischemic discoloration. Complete resolution was noted by treatment day 3 in one case and near complete resolution by day 16 in the second. Case 3 expired on hospital day four from an unrelated intracranial hemorrhage. No complications or digital loss were observed. Onabotulinum toxin type A as an off-label treatment for digital ischemia was demonstrated to be safe and effective in pediatric and neonatal patients. Clinical improvement was noted in all patients by post-procedure day one, with two patients demonstrating near to complete resolution within 3 weeks. Export

1 January 2022
Verified
Conference Paper
Open access
PDF file
SHSamantha Huang
Samantha Huang
ECEthan Chi
Ethan Chi
NCNathan Chi
Nathan Chi
Samantha Huang, Ethan Chi, Nathan Chi. Proceedings of the 16th International Workshop on Semantic Evaluation (SemEval-2022). 2022.